Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.410
-0.070 (-4.73%)
Feb 19, 2026, 10:45 AM EST - Market open

Celularity Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
40.5854.2222.7717.9821.3414.28
Revenue Growth (YoY)
-15.81%138.11%26.68%-15.75%49.43%-32.48%
Cost of Revenue
20.0414.9916.0219.679.654.93
Gross Profit
20.5439.236.76-1.6911.689.35
Selling, General & Admin
52.2658.6450.5866.0262.2131.34
Research & Development
15.5117.3930.4778.3684.9752.71
Amortization of Goodwill & Intangibles
1.441.752.192.192.193.39
Operating Expenses
69.2177.7883.23146.58149.3787.44
Operating Income
-48.67-38.55-76.48-148.27-137.69-78.09
Interest Expense
-7.67-6.26-3.02--3.17-2.35
Interest & Investment Income
0.280.330.320.370.330.37
Other Non Operating Income (Expenses)
-17.7-9.2-0.1341.9611.8-54.59
EBT Excluding Unusual Items
-73.77-53.69-79.3-105.94-128.72-134.67
Merger & Restructuring Charges
-----7.19-
Impairment of Goodwill
---112.35-3.61--
Gain (Loss) on Sale of Assets
------4.43
Asset Writedown
------129.4
Legal Settlements
-----5.33-
Other Unusual Items
-6.88-4.21103.16123.7641.1555.57
Pretax Income
-80.65-57.89-196.2914.21-100.1-212.93
Income Tax Expense
--0.010.010.02-4.7
Net Income
-80.65-57.89-196.314.19-100.12-208.23
Net Income to Common
-80.65-57.89-196.314.19-100.12-208.23
Shares Outstanding (Basic)
2422181472
Shares Outstanding (Diluted)
2422181572
Shares Change (YoY)
13.94%22.89%18.89%123.44%264.09%-22.85%
EPS (Basic)
-3.35-2.64-11.021.01-14.93-113.06
EPS (Diluted)
-3.35-2.64-11.020.95-14.93-113.06
Free Cash Flow
-6.65-6.56-39.73-143.11-116.3-91.03
Free Cash Flow Per Share
-0.28-0.30-2.23-9.55-17.34-49.42
Gross Margin
50.61%72.36%29.67%-9.40%54.75%65.46%
Operating Margin
-119.95%-71.10%-335.86%-824.85%-645.35%-546.93%
Profit Margin
-198.75%-106.77%-862.04%78.95%-469.27%-1458.42%
Free Cash Flow Margin
-16.38%-12.10%-174.49%-796.17%-545.11%-637.53%
EBITDA
-41.36-30.63-67.16-138.83-128.87-69.92
EBITDA Margin
-101.92%-56.49%-294.91%---
D&A For EBITDA
7.327.929.329.448.828.17
EBIT
-48.67-38.55-76.48-148.27-137.69-78.09
EBIT Margin
-119.95%-71.10%----
Effective Tax Rate
---0.09%--
Revenue as Reported
40.5854.2222.7717.9821.3414.28
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q